植入物支架角度和高度对植入物周围组织健康的影响:随机对照临床试验的回顾性分析
The International journal of prosthodontics
|February 21, 2024
概括
对于患有围植入体炎风险较低的患者来说,既没有宽的支柱突出角度,也没有短的恢复边缘到骨距离,这都不会对边缘围植入体骨稳定性产生负面影响. 基支柱没有比单片支柱更宽的浮出角度.
科学领域:
- 牙科植入物学 牙科植入物学
- 牙周病学 牙周病学
- 生物材料科学 生物材料科学
背景情况:
- 牙周植入物骨稳定性对于长期的牙科植入物成功至关重要.
- 支架的设计和定位可能会影响植入周围的骨水平.
- 了解这些因素是预防围植入炎的关键.
研究的目的:
- 为了研究支柱突出角度和高度对边缘围植入物骨稳定性的影响.
- 为了比较基 (Ti-base) 和单片基之间的支柱出现角度.
- 评估这些因素在没有患上围部植入炎倾向的患者中.
主要方法:
- 一项纵向研究在5年内评估了48个支柱 (24个Ti基,24个单件).
- 临床和放射性评估在基线,一年后,然后每年进行一次.
- 分析了支柱参数和边缘骨水平之间的相关性.
主要成果:
- 在4-5年后,在单片支柱的 mesial 侧观察到浮出角度 (>30度) 和骨稳定性之间的中度负相关性.
- 对于恢复边缘和尖顶骨之间的距离≤1.5毫米,对于任何一个支柱类型都没有发现显著的负相关性.
- 与一块的支柱相比,Ti基支柱没有显示出更宽的浮出角度.
结论:
- 在低风险患者中,增加的支柱突出角度 (>30度) 和短边缘至骨边距离 (≤1.5毫米) 与边缘周植入骨损失无关.
- 支柱的类型 (Ti-基与单片) 不会影响浮出角度.
- 这些发现支持可预测的周围植入物骨维护,在非敏感患者中具有各种支柱结构.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


